Skip to main content

Gamma Technologies acquires ProFEMAG portfolio

| News

Gamma Technologies acquires ProFEMAG portfolio


The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based in the US State of Illinois is now planning to establish a Global Center of Excellence for electrical machines in Basel.

Gamma Technologies (GT) is acquiring the FEMAG software portfolio. FEMAG is an electromagnetic simulation solution for electrical machines based on the physical finite element method. It has been continually further developed and enhanced by ProFEMAG AG and Semafor Informatik und Energie AG, which are both based in Basel. The project was first launched at the Institute of Electrical Machines at the Swiss Federal Institute of Technology in Zurich (ETH) in 1982.

FEMAG technologies have been integrated in the GT-SUITE system simulation platform from Gamma Technologies. They facilitate “a complete design solution for batteries, electric drives and power electronics”, explains Dimple Shah, GT President and CEO, in a press release issued by his company.

Global Center of Excellence in Basel

“The tight integration of our solutions into the GT-SUITE system simulation platform has opened new possibilities for the engineering community”, comments Walter Egli, CEO of ProFEMAG, in the press release, before adding that GT’s culture of innovation “provides an excellent home for FEMAG technologies and people”.  According to Dr. Ronald Tanner, CTO of Semafor, this “next chapter with GT” will enable the company “to accelerate the pace of development”.

For future cooperation with ProFEMAG and Semafor, GT plans to set up a Global Center of Excellence in Basel. This will be an innovation hub for the research, development and deployment of multiphysics simulation technologies for the next generation of high-efficiency electric machine applications. The investment and innovation promotion agency Basel Area Business & Innovation will be supporting this project.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More